Skip to main content

InMed Pharmaceuticals Inc.

INM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001728328

In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.

Members of Congress who traded INM

No member of Congress has reported a trade in InMed Pharmaceuticals Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.